IRIS
DE MARCHI, Fabiola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.567
AS - Asia 2.659
NA - Nord America 2.494
SA - Sud America 365
AF - Africa 184
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.275
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.376
RU - Federazione Russa 1.130
SG - Singapore 1.011
IE - Irlanda 620
IT - Italia 527
CN - Cina 484
HK - Hong Kong 359
VN - Vietnam 356
DE - Germania 353
BR - Brasile 271
SE - Svezia 247
FR - Francia 180
BJ - Benin 115
GB - Regno Unito 102
KR - Corea 95
UA - Ucraina 94
IN - India 91
CA - Canada 64
FI - Finlandia 53
JP - Giappone 46
PL - Polonia 44
MX - Messico 40
NL - Olanda 37
AR - Argentina 36
AT - Austria 35
TR - Turchia 35
BD - Bangladesh 32
ID - Indonesia 29
ZA - Sudafrica 28
ES - Italia 25
EE - Estonia 21
IR - Iran 21
CZ - Repubblica Ceca 19
IQ - Iraq 18
DK - Danimarca 14
CL - Cile 13
EC - Ecuador 13
LT - Lituania 13
RO - Romania 12
JO - Giordania 11
AE - Emirati Arabi Uniti 10
BE - Belgio 10
DZ - Algeria 10
CO - Colombia 9
PK - Pakistan 9
VE - Venezuela 8
MA - Marocco 7
PH - Filippine 7
TN - Tunisia 7
CH - Svizzera 6
PY - Paraguay 6
DO - Repubblica Dominicana 5
GR - Grecia 5
LB - Libano 5
UZ - Uzbekistan 5
AU - Australia 4
KE - Kenya 4
MY - Malesia 4
NP - Nepal 4
PE - Perù 4
SA - Arabia Saudita 4
TH - Thailandia 4
BO - Bolivia 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
AO - Angola 2
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
CY - Cipro 2
HU - Ungheria 2
KZ - Kazakistan 2
LV - Lettonia 2
NG - Nigeria 2
RS - Serbia 2
SI - Slovenia 2
UY - Uruguay 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GT - Guatemala 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
Totale 9.266
Salva come PNG Salva come JPEG
Città #
Dublin 616
Singapore 365
Hong Kong 355
San Jose 308
Ashburn 256
Beijing 179
Jacksonville 141
Los Angeles 125
Moscow 122
Ho Chi Minh City 118
Cotonou 115
Lauterbourg 103
Seoul 90
Munich 70
Chandler 67
Hanoi 64
New York 60
Dearborn 58
Novara 55
Buffalo 52
Dallas 47
Rome 47
Turin 47
Mülheim 44
Orem 44
Frankfurt am Main 40
Milan 37
Lawrence 35
Princeton 35
Boardman 34
Falkenstein 32
Wilmington 32
Santa Clara 31
São Paulo 31
Tokyo 31
Warsaw 31
Helsinki 29
Chennai 28
Stockholm 27
Bremen 24
Nuremberg 24
Strasbourg 24
Amsterdam 23
Council Bluffs 23
Montreal 22
Toronto 22
Brooklyn 21
Johannesburg 21
Houston 20
Mexico City 19
Vienna 19
London 18
Phoenix 18
San Mateo 17
Denver 16
The Dalles 16
Atlanta 15
Brno 15
Da Nang 15
Poplar 15
Seattle 15
Vercelli 15
Ankara 14
Piemonte 14
Rio de Janeiro 14
Jakarta 13
Manchester 13
Tianjin 13
Chicago 12
Redondo Beach 12
Turku 12
Zanjan 12
Amman 11
Hangzhou 11
Boston 10
Brussels 10
Haiphong 10
Monmouth Junction 10
Hillsboro 9
Hải Dương 9
Kocmyrzów 9
Mumbai 9
Villadossola 9
Guangzhou 8
Kocaeli 8
New Delhi 8
Baghdad 7
Borgomanero 7
Dhaka 7
Ottawa 7
Querétaro 7
San Francisco 7
Santiago 7
Ann Arbor 6
Cassano Magnago 6
Genoa 6
Guarulhos 6
Porto Alegre 6
Quận Bình Thạnh 6
Roubaix 6
Totale 4.789
Salva come PNG Salva come JPEG
Nome #
Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: current evidence and potential use. 240
Retrospective observational study on the use of acetyl-L-carnitine in ALS 187
Advances in stem cell therapy for amyotrophic lateral sclerosis 172
Analysis of the GCG Repeat Length in NIPA1 Gene in C9orf72-mediated ALS in a Large Italian ALS Cohort 156
ALS Phenotype Is Influenced by Age, Sex, and Genetics: A Population-Based Study 146
A case of marchiafava bignami disease with frontal cortex involvement and late onset, long-lasting psychiatric symptoms 137
Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases 124
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 124
Chronic obstructive pulmonary disease may complicate Alzheimer's disease: a comorbidity problem 123
Ptosis and bulbar onset: an unusual phenotype of familial ALS? 121
A case of Progressive Non-Fluent Aphasia as onset of Amyotrophic Lateral Sclerosis with FrontoTemporal Dementia 119
A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis 117
Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? 116
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 114
Study protocol on the safety and feasibility of a normocaloric ketogenic diet in people with amyotrophic lateral sclerosis 114
Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies 110
Detection of white matter ultrastructural changes for amyotrophic lateral sclerosis characterization: A diagnostic study from DTI-derived data 110
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocol 108
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 107
The length of SNCA Rep1 microsatellite may influence cognitive evolution in Parkinson’s disease 107
Headache in immigrant patients: similarities and differences with Italian population 107
Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy 107
The Potential Role of Peripheral Oxidative Stress on the Neurovascular Unit in Amyotrophic Lateral Sclerosis Pathogenesis: A Preliminary Report from Human and In Vitro Evaluations 106
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 106
null 105
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 104
Frontotemporal Dementia Presenting as Gambling Disorder: When a Psychiatric Condition Is the Clue to a Neurodegenerative Disease 99
Adopting Assistive Technologies in Healthcare Processes: A Chatbot for Patients with Amyotrophic Lateral Sclerosis 98
Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions 96
Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis 94
Effects of Acetyl-L-Carnitine on Oxidative Stress in Amyotrophic Lateral Sclerosis Patients: Evaluation on Plasma Markers and Members of the Neurovascular Unit 94
Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2: a case series 94
C9ORF72 Repeat Expansion Affects the Proteome of Primary Skin Fibroblasts in ALS 94
Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats 93
A pilot trial of RNS60 in amyotrophic lateral sclerosis 92
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 92
Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients 90
Occipital Neuralgia in Chiari I Malformation: Two Different Events or Two Different Faces of the Same Event? 90
Depression and risk of Cognitive Dysfunctions in Amyotrophic Lateral Sclerosis 89
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers 88
Circulating GLAST+ EVs are increased in amyotrophic lateral sclerosis 86
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives 86
The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics 84
Accelerated early progression of amyotrophic lateral sclerosis over the covid-19 pandemic 83
Marchiafava-Bignami Disease with frontal cortex involvement and late onset, long-lasting psychiatric symptoms: A case report 82
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 81
Coupling motor evoked potentials and brain [18F]FDG-PET in Amyotrophic Lateral Sclerosis: preliminary findings on disease severity 80
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 79
Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment 79
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 78
Telehealth Approach For Amyotrophic Lateral Sclerosis Patients: The experience during COVID-19 pandemic 78
Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 77
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis 77
Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients 77
Adjusted cost analysis of video televisits for the care of people with amyotrophic lateral sclerosis 73
Factors associated with the severity of COVID-19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID-19 Registry 73
Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19 73
Respiratory support in a population-based ALS cohort: Demographic, timing and survival determinants 72
Shotgun Proteomics Links Proteoglycan-4+ Extracellular Vesicles to Cognitive Protection in Amyotrophic Lateral Sclerosis 71
A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine 71
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 70
A Telehealth Intervention for Nutritional Counseling in Amyotrophic Lateral Sclerosis Patients 69
Telehealth in neurodegenerative diseases: Opportunities and challenges for patients and physicians 69
The Role of Tau beyond Alzheimer’s Disease: A Narrative Review 68
Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients 67
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact 66
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents 66
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients 65
Novel Therapeutic Strategies in Alzheimer's Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond 65
Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene 65
Clinical and Metabolic Signature of UNC13A rs12608932 Variant in Amyotrophic Lateral Sclerosis 64
Withdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey 64
Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment 64
Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis? 64
Profiling cognition and brain metabolism in amyotrophic lateral sclerosis and frontotemporal dementia 64
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis 64
Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome 64
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses 63
From Mild Cognitive Impairment to Dementia: The Impact of Comorbid Conditions on Disease Conversion 62
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder 62
Editorial: What's next? Innovative translational markers across the ALS-FTD continuum 61
What is amyotrophic lateral sclerosis prevalence? 61
Predicting Cognitive Decline in Parkinson's Disease: Can We Ask the Genes? 61
From Biomarkers to Precision Medicine in Neurodegenerative Diseases: Where Are We? 59
Effect of mesenchymal stromal cell transplantation on long-term survival in amyotrophic lateral sclerosis 59
Identification of Transcriptomic Differences in Induced Pluripotent Stem Cells and Neural Progenitors from Amyotrophic Lateral Sclerosis Patients Carrying Different Mutations: A Pilot Study 59
The diagnostic and prognostic role of biomarkers for amyotrophic lateral sclerosis 59
Cell therapy in ALS: An update on preclinical and clinical studies 58
Clinical trials in pediatric ALS: a TRICALS feasibility study 58
Challenging the boundaries: c9orf72 mutation presenting as Alzheimer's disease 58
Exploring the phenotypic fingerprints of ANXA11 variants in ALS: a population-based study in an European cohort 57
Variability in Clinical Phenotype in TARDBP Mutations: Amyotrophic Lateral Sclerosis Case Description and Literature Review 56
Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders 55
Gastrointestinal Status and Microbiota Shaping in Amyotrophic Lateral Sclerosis: A New Frontier for Targeting? 54
Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis 52
Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale 50
Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it? 50
Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort 50
Effects of acetyl L-carnitine on oxidative stress in Amyotrophic Lateral Sclerosis patients: evaluation on plasma markers and on members of the neurovascular unit 49
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patients 48
Totale 8.569
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.232
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.232
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 0 0 0 9 34 8
2021/2022304 20 11 15 26 16 7 2 7 23 16 73 88
2022/20231.230 45 56 40 10 82 88 46 54 667 17 98 27
2023/2024571 50 38 80 29 82 20 76 5 13 5 50 123
2024/20251.855 45 38 125 36 50 196 120 164 339 172 168 402
2025/20264.896 289 206 288 687 669 405 748 881 369 354 0 0
Totale 9.472